News & Updates

Patients with chronic hepatitis D virus (HDV) infection appear to respond to treatment with the combination of tobevibart plus elebsiran, according to the phase II, open-label SOLSTICE trial.

In patients with newly diagnosed glioblastoma, the use proton pump inhibitors (PPI) may be detrimental to survival, according to a meta-analysis.

Treatment with the first-in-class oral nonazole, triterpenoid antifungal ibrexafungerp appears to be efficacious and well-tolerated in patients with recurrent vulvovaginal candidiasis, as shown in the phase III CANDLE study.

Treatment with nipocalimab is safe and helps improve clinical disease activity in patients with moderate-to-severe, active Sjögren's disease, according to the phase II DAHLIAS trial.

Treatment with olezarsen significantly reduced triglyceride levels and the risk of acute pancreatitis in patients with severe hypertriglyceridaemia, according to the primary results of the CORE-TIMI 72a and CORE2-TIMI 72b trials presented at AHA 2025.

Exposure to oral corticosteroids during pregnancy is not associated with the risk of gestational diabetes mellitus (GDM), except for a modest increase during an early exposure window, as shown in a study from South Korea.

Infants exposed to antiretroviral treatment (ART) regimens containing integrase strand transfer inhibitors (INSTIs) in utero seem to fare as well as their nonexposed peers in terms of neurodevelopment, as reported in a study.

Patients who discontinue tenofovir alafenamide (TAF) therapy appear to have a higher hepatitis B virus relapse rate than those who ceased entecavir or tenofovir disoproxil fumarate (TDF) therapy, according to a recent study.

The use of aspirin among pregnant patients with inflammatory bowel disease (IBD) does not appear to increase the risk of disease severity, reports a study. Low-dose aspirin (LDA) has been prescribed to nearly a third of IBD patients during pregnancy.

Treatment with the pan-AKT inhibitor ipatasertib appears to induce response in patients with tumours harbouring AKT1E17K mutations, according to a study.